North America dominates the Trastuzumab Injection Market with advanced oncology infrastructure and high treatment adoption rates across healthcare systems. The United States leads in biosimilar uptake, reimbursement policies, and comprehensive cancer center networks. Europe follows with strong regulatory frameworks supporting biosimilar interchangeability and competitive pricing mechanisms. The...